MURFREESBORO, TN / ACCESSWIRE / April 20, 2022 / National Health Investors, Inc. (NYSE:NHI) announced details for the release of its results for the first quarter ended March 31, 2022. NHI plans to issue its earnings release after the market closes on Monday, May 9, 2022, and will host a conference call on the following day, Tuesday, May 10, 2022, at 12:00 p.m. Eastern Time to discuss the results. The number to call for this interactive teleconference is (800) 941-4658, with the confirmation number 22016962.
The live broadcast of the conference call will be available online at www.nhireit.com and at https://www.webcaster4.com/Webcast/Page/633/45019 on Tuesday, May 10, 2022, at 12:00 p.m. Eastern Time. The online replay will be available shortly after the call and remain available for one year.
About NHI
Incorporated in 1991, National Health Investors, Inc. (NYSE:NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI’s portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals. For more information, visit www.nhireit.com.
Contact:
Dana Hambly, Vice President, Finance and Investor Relations
Phone: (615) 890-9100
SOURCE: National Health Investors
View source version on accesswire.com:
https://www.accesswire.com/698198/NHI-Announces-First-Quarter-2022-Earnings-Release-and-Conference-Call-Date
Halifax, Nova Scotia--(Newsfile Corp. - June 26, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB:…
Dallas, Georgia--(Newsfile Corp. - June 26, 2024) - Bemax Inc. (OTC Pink: BMXC), a private…
Elevate your practice and revolutionize patient care with the all-new user-friendly design and the same…
Study published in peer-reviewed journal finds BioStem’s products offer overall better treatment efficiency, and greater…
AXA is the 2nd Largest Provider of Private Medical Insurance in the UK Payer Coverage…
Ongoing Study is Investigating RenovoGem™ to treat Locally Advanced Pancreatic CancerLOS ALTOS, Calif., June 26, 2024…